Skip to content

Logan Neitzke-Spruill

14 papers in the library · 181 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care

FOCUS: The Journal of Lifelong Learning in Psychiatry July 1, 2026 Lynnette A. Averill, Logan Neitzke-Spruill

Psychedelic-assisted therapies (PATs) are emerging as novel combination treatments for selected stress- and trauma-related psychiatric conditions, particularly in cases where existing pharmacologic and psychotherapeutic approaches have provided limited benefit. Although current mechanistic models emphasize neuroplasticity, large-scale network changes, and modulation of neurotransmitter systems,...

DOI: 10.1176/appi.focus.20260006 (opens in new tab) Action physics Context archaeology Interpersonal communication Vulnerability computing +7

The spectrum of potential benefits and ethical considerations for psychedelic-assisted therapy in autistic adults

Psychedelics May 1, 2026 Madeleine Cluck, Alison B. Purcell, Zuzana Kazan et al.

There is currently an ongoing resurgence in research on the therapeutic potential of psychedelics for psychiatric conditions. Psychedelic-assisted therapy (PAT) differs from most current forms of psychiatric treatment in two primary domains: its requirement for fewer doses (often just one), and its documented ability to promote profound insights, introspection, and cognitive shifts. Autism...

DOI: 10.1016/j.psyche.2026.100020 (opens in new tab) Autistic spectrum disorder Autism Action physics Spectrum functional analysis +3

US Institutional Review Board Perspectives Regarding Psychedelic Research

Psychedelic Medicine April 23, 2026 Jill Oliver Robinson, Ruiying (aria) Xiong, Logan Neitzke-Spruill et al.

Background: Institutional review boards (IRBs) are gatekeepers of psychedelic research, deciding whether and under what conditions it may proceed. Yet IRB understanding, attitudes, perspectives, and concerns regarding psychedelics and psychedelic research have not previously been studied. These factors are important to assessing whether US IRBs are likely to be over- or underprotective of...

Reported Safety Practices of Publicly Advertised Psychedelic Retreats.

JAMA Network Open January 2, 2026 Amy L. Mcguire, Logan Neitzke-Spruill, Jill O. Robinson et al. 4 citations

Importance: The availability of psychedelic retreats has grown to meet the demand for access to these substances. Despite centuries of use among Indigenous communities, psychedelics can pose serious risks for some users. Objective: To determine safety precautions that retreat organizations that offer psychedelic substances currently use. Design, Setting, and Participants: This qualitative study...

From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care

Translational Behavioral Medicine 2026 Joshua Mitchell, Logan Neitzke-Spruill, David S. Mathai et al. 1 citation

BACKGROUND: Psychedelics such as 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin are showing promising results in clinical trials for the treatment of mental health disorders, including post-traumatic stress disorder, addiction, and treatment-resistant depression. US Food and Drug Administration approval may be on the horizon. Yet, little is known about how these treatments will move...

An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Nature Medicine June 3, 2025 Chloé Pronovost-Morgan, Kyle T. Greenway, Leor Roseman et al. 26 citations

Psychedelic substances exhibit complex interactions with the 'set and setting' of use, that is, the mental state of the user and the environment in which a psychedelic experience takes place. Despite these contextual variables' known importance, psychedelic research has lacked methodological rigor in reporting extra-pharmacological factors. This study aimed to generate consensus-based...

DOI: 10.1038/s41591-025-03685-9 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Therapeutic protocols Clinical guidelines Mental health treatment +1

A landscape analysis of psychedelic retreat organizations advertising online

PLoS One May 2, 2025 Nikita Singh, Srijith Kambala, Logan Neitzke-Spruill et al. 10 citations

Research into psychedelics’ clinical potential has corresponded to a growth in public interest and adult use. One common pathway to accessing psychedelics is through psychedelic retreats. While individual retreats have been characterized in the anthropological literature, no systematic evaluation of the psychedelic retreat industry exists. Assessing the characteristics of the psychedelic...

Integrating the ineffable: a social phenomenological analysis of the psychedelic experience

Library, Museums and Press - UDSpace (University of Delaware) February 4, 2025 Logan Neitzke-Spruill 2 citations

"There has been a renewed and growing interest in psychedelic drugs in the 21st century. Drawing on social-phenomenology, cognitive sociology, and ‘set and setting’ theory, I delineate how individuals use socially defined frameworks of understanding to attribute meaning to psychedelic experiences. These frameworks refer to the ‘ready-made’ schemes that structure subjective experience of...

DOI: 10.58088/dyjg-0344 (opens in new tab) Interpretative phenomenological analysis Epistemology

Supportive Touch in Psychedelic Assisted Therapy.

The American Journal of Bioethics 2025 Logan Neitzke-Spruill, Caroline Beit, Lynnette A. Averill et al. 19 citations

In August 2024, The U.S. Food and Drug Administration rejected Lykos Therapeutics, Inc.'s new drug application for midomafetamine with psychological intervention (MDMA-AT) to treat post-traumatic stress disorder (PTSD). Among the many issues raised during review was concern about a highly publicized case of alleged sexual misconduct by an unlicensed therapist during a Phase 2 study of MDMA and...

Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study

Brazilian Journal of Psychiatry 2025 David S. Mathai, Jill O. Robinson, Kevin Wagner et al. 1 citation

OBJECTIVE: Despite growing research on the potential mental health benefits of psychedelics, there has been limited study of these drugs in populations with obsessive-compulsive disorder (OCD) and with Hispanic and Latin American (H/L) ancestry. METHODS: Demographic and clinical assessments were conducted as part of the Latin American Trans-ancestry Initiative for OCD genomics (LATINO) Study in...

A Transformative Trip? Experiences of Psychedelic Use

Neuroethics June 20, 2024 Logan Neitzke-Spruill, Caroline Beit, Jill O. Robinson et al. 26 citations

Psychedelic experiences are often compared to “transformative experiences” due to their potential to change how people think and behave. This study empirically examines whether psychedelic experiences constitute transformative experiences. Given psychedelics’ prospective applications as treatments for mental health disorders, this study also explores neuroethical issues raised by the...

DOI: 10.1007/s12152-024-09567-0 (opens in new tab) Full text (opens in new tab) Psychedelics Transformative experience Agency Moral neuroenhancement +2

Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications

Perspectives in biology and medicine 2024 Logan Neitzke-Spruill, Neşe Devenot, Dominic Sisti et al. 7 citations

ABSTRACT:Psychedelics have again become a subject of widespread interest, owing to the reinvigoration of research into their traditional uses, possible medical applications, and social implications. As evidence for psychedelics' clinical potential mounts, the field has increasingly focused on searching for mechanisms to explain the effects of psychedelics and therapeutic efficacy of...

Race as a component of set and setting: How experiences of race can influence psychedelic experiences

Journal of Psychedelic Studies September 19, 2019 Logan Neitzke-Spruill 58 citations

Background and aims Set and setting function both as a concept that guides research and practice with psychedelic drugs and as a meme aimed at reducing harm among psychedelic users. Referring to non-pharmacological factors that shape drug experiences, the concept of set and setting was popularized in the West during the mid-20th century. However, little theoretical development has occurred...

DOI: 10.1556/2054.2019.022 (opens in new tab) Full text (opens in new tab) Psychosocial Race biology Harm Mental health +5

A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience

Journal of Psychoactive Drugs August 8, 2018 Logan Neitzke-Spruill, Carol Glasser 27 citations

Psychedelic drugs, or entheogens, have been used for religious purposes among various cultures for thousands of years. Recently, these substances have caught the attention of Westerners for many reasons, including their propensity to induce mystical experiences. This study examined the relationship between religion and having mystical experiences. A total of 119 participants were drawn from...